E-LIB Suche - Ergebnisse für: Marcel Nijland

1

Primary therapy and survival in patients aged over 70-years..:

Matthijs van der Meulen ; Jacoline E.C. Bromberg ; Marcel Nijland...
Haematologica. 106 (2020) 2 - p. 597-600 , 2020

Link: https://doi.org/10.3324/..

2

Combining brentuximab vedotin with dexamethasone, high-dose..:

Marie José Kersten ; Julia Driessen ; Josée M. Zijlstra...
Haematologica. 106 (2020) 4 - p. 1129-1137 , 2020

Link: https://doi.org/10.3324/..

3

Treatment of patients with MYC rearrangement positive large..:

Martine E.D. Chamuleau ; Coreline N. Burggraaff ; Marcel Nijland...
Haematologica. 105 (2019) 12 - p. 2805-2812 , 2019

Link: https://doi.org/10.3324/..

4

Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC..:

de Jonge, A. Vera ; Duetz, Carolien ; Bruins, Wassilis S. C....
Blood Advances. 8 (2024) 5 - p. 1094-1104 , 2024

Link: https://doi.org/10.1182/..

5

Detection of circulating tumor DNA in plasma of patients wi..:

Zhong, Yujie ; Tan, Geok Wee ; Bult, Johanna...
BMC Cancer. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

6

Treatment strategies and outcome in relapsed peripheral T-c..:

Brink, Mirian ; Huisman, Francien ; Meeuwes, Frederik O....
Blood Advances. 8 (2024) 14 - p. 3619-3628 , 2024

Link: https://doi.org/10.1182/..

7

P1159: INFERIOR OUTCOME OF FRAIL AND UNFIT PATIENTS WITH DI..:

Al-Sarayfi, Diana ; Brink, Mirian ; Chamuleau, Martine E. D....
HemaSphere. 7 (2023) S3 - p. e48093ff , 2023

Link: https://doi.org/10.1097/..

8

A population-based study of transformed marginal zone lymph..:

Bult, Johanna A. A. ; Huisman, Francien ; Zhong, Yujie...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

9

S222: EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVID..:

Sureda, Anna ; Falchi, Lorenzo ; Leppa, Sirpa...
HemaSphere. 7 (2023) S3 - p. e5547136 , 2023

Link: https://doi.org/10.1097/..

10

Zoonotic Transmission of Vaccine-Derived Bordetella bronchi..:

Kraai, Imke ; Knoester, Marjolein ; Bathoorn, Erik..
Open Forum Infectious Diseases. 10 (2023) 8 - p. , 2023

Link: https://doi.org/10.1093/..

11

IBCL-474 Epcoritamab + R2 Regimen and Responses in Patients..:

Merryman, Reid W. ; Belada, David ; Sureda, Anna...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S454 , 2023

Link: https://doi.org/10.1016/..

12

Survival, neurocognitive function, and health-related quali..:

Bromberg, Jacoline E C ; Issa, Samar ; van der Holt, Bronno...
Neuro-Oncology. 26 (2023) 4 - p. 724-734 , 2023

Link: https://doi.org/10.1093/..

13

POSTER: IBCL-474 Epcoritamab + R2 Regimen and Responses in ..:

Merryman, Reid W. ; Belada, David ; Sureda, Anna...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S210 , 2023

Link: https://doi.org/10.1016/..

14

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly d..:

Chamuleau, Martine E D ; Stenner, Frank ; Chitu, Dana A...
The Lancet Haematology. 10 (2023) 12 - p. e966-e975 , 2023

Link: https://doi.org/10.1016/..

15

A non-randomized risk-adjusted comparison of lenalidomide +..:

de Jonge, A. Vera ; van Werkhoven, Erik ; Dinmohamed, Avinash G....
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..